Intracavernous Injection of Platelet-Rich Plasma Reverses Erectile Dysfunction of Chronic Cavernous Nerve Degeneration Through Reduction of Prostate Hyperplasia: Evidence From an Aging-Induced Erectile Dysfunction Rat Model

    March 2023 in “ The FASEB Journal ”
    Huai‐Ching Tai, Wei‐Kung Tsai, Meng‐Lin Chang, Chellappan Praveen Rajneesh, Xiao‐Wen Tseng, Wen‐Chun Hsu, Yi‐No Wu, Han‐Sun Chiang
    New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide →
    Studysummary This study found that platelet-rich plasma treatment significantly improved erectile function and restored neural structures in aged rats with erectile dysfunction, suggesting potential benefits for geriatric patients. Our plain-language summary of this paper — not a Tressless recommendation.
    The study examined the impact of intracavernous platelet-rich plasma (PRP) injections on erectile dysfunction (ED) and prostate hyperplasia in an aging-induced ED rat model, involving 30 male Sprague-Dawley rats. PRP treatment improved erectile function by increasing intracavernous pressure and reducing prostate gland volume, indicating a decrease in prostate hyperplasia. The therapy also promoted nerve regeneration and tissue repair, suggesting that PRP could be a promising, cost-effective treatment for aging-associated ED and prostate hyperplasia.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results